Laboratory Corp. of America Holdings (LH)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Laboratory Corp. of America Holdings (LH)
Go deeper and ask any question about LH
Company Performance
Current Price
as of Sep 13, 2024$221.13
P/E Ratio
41.99
Market Cap
$18.53B
Description
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.
Metrics
Overview
- HQBurlington, NC
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerLH
- Price$221.13+0.49%
Trading Information
- Market Cap$18.53B
- Float99.65%
- Average Daily Volume (1m)429,107
- Average Daily Volume (3m)571,453
- EPS$5.30
Company
- Revenue$12.49B
- Rev Growth (1yr)6.17%
- Net Income$205.30M
- Gross Margin26.83%
- EBITDA Margin14.38%
- EBITDA$463.30M
- EV$22.88B
- EV/Revenue1.83
- P/E41.99
- P/S1.49